Duration of Follow-Up Counselling on Smoking Cessation Outcomes

Sponsor

National University Hospital, Singapore (Other)

Overall Status

Completed

CT.gov ID

NCT01893502

Collaborator

(none)

Enrollment

Location

Arms

33.5

Duration (Months)

0.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Smoking cessation improves mortality, even in patients with existing smoking-related morbidity. Telephone follow-up after smoking cessation counselling as been shown to be an important method to provide support to smokers and to improve quit rates, especially if three or more calls were used in addition to face-to-face counselling. While it is reasonable to assume that more counselling leads to better smoking cessation outcomes, little evidence exists over the amount of telephone follow-up counselling that is required for optimal and sustained abstinence. We aim to investigate if six-months of weekly telephone follow-up is superior to one-month of weekly telephone follow-up.

Condition or Disease	Intervention/Treatment	Phase
Smoking Cessation	Behavioral: Telephone counselling from Quitline	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

11 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Outcomes Assessor)

Primary Purpose:

Treatment

Official Title:

Smoke Free Randomized Controlled Trial

Study Start Date :

Jun 1, 2013

Actual Primary Completion Date :

Mar 18, 2016

Actual Study Completion Date :

Mar 18, 2016

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Group 1 Participants will receive weekly proactive and live telephone counselling from Quitline (run by the Health Promotion Board) for one month	Behavioral: Telephone counselling from Quitline
Active Comparator: Group 2 Participants will receive weekly proactive and live telephone counselling from Quitline (run by the Health Promotion Board) for six months	Behavioral: Telephone counselling from Quitline

Arm

Intervention/Treatment

Active Comparator: Group 1

Participants will receive weekly proactive and live telephone counselling from Quitline (run by the Health Promotion Board) for one month

Behavioral: Telephone counselling from Quitline

Active Comparator: Group 2

Participants will receive weekly proactive and live telephone counselling from Quitline (run by the Health Promotion Board) for six months

Behavioral: Telephone counselling from Quitline

Outcome Measures

Primary Outcome Measures

Seven-day point prevalence abstinence [Six months]

Secondary Outcome Measures

Average number of cigarettes smoked per day over the past seven days [3, 6, 12 months]

Other Outcome Measures

Exhaled carbon monoxide levels [3, 6, 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Current smokers among outpatients, including hospital employees, who provide informed consent for enrollment in the smoking cessation program

Exclusion Criteria:

Subjects who decline smoking cessation or who do not provide informed consent
Subjects who are participating or will be participating in other smoking cessation programs within the next six months
Subjects who are currently using smoking cessation medications
Subjects who cannot be followed up for at least six months, for instance, subjects who would be resigning and going overseas within the next six months
Subjects with language limitations that would impede completion of self-administered questionnaires
Subjects who are difficult to communicate with over the telephone (e.g. having speech or hearing problems)
Subjects with cognitive impairments that would impede counselling and follow-up
Subjects with no telephone number
Subjects who are too sick to receive smoking cessation counselling
Subjects with limited life expectancy (e.g. metastatic cancer)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	National University Hospital	Singapore		Singapore	119228

Sponsors and Collaborators

National University Hospital, Singapore

Investigators

Principal Investigator: Kay C See, MBBS, National University Hospital, Singapore

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Medicine, Dr. See Kay Choong, National University Hospital, Singapore

ClinicalTrials.gov Identifier:

NCT01893502

Other Study ID Numbers:

2013/00057

First Posted:

Jul 9, 2013

Last Update Posted:

Apr 7, 2017

Last Verified:

Apr 1, 2017

Study Results

No Results Posted as of Apr 7, 2017